For decades, the search for an “autism treatment” has been hampered by a fundamental flaw: the assumption that autism is a single condition. In reality, autism spectrum disorder (ASD) is a genetic mosaic, meaning a drug that helps one person may be useless—or even harmful—to another. A groundbreaking study from Yale University is now attempting … Read more
Your housemates, partners, and closest friends aren’t just sharing your living space—they are quietly rewriting your internal biology. While we have long understood that diet and geography shape the gut microbiome, new research suggests that the depth of our social bonds may be just as influential, creating a shared biological ecosystem among those we hold … Read more
The End of Reactive Medicine: AI’s Shift Toward ‘Tipping Point’ Forecasting For decades, the gold standard of medicine has been early detection—finding a tumor or a biomarker while it is still small enough to treat. But “early” has always been defined by the presence of a visible pathology. A groundbreaking editorial published in Intelligent Medicine … Read more
For patients facing high-grade neuroendocrine tumors (NETs), the medical landscape has long been defined by a stark reality: limited options and a devastatingly aggressive disease progression. However, a new clinical trial at the Sylvester Comprehensive Cancer Center is attempting to rewrite this narrative by shifting the strategy from systemic toxicity to precision immunotherapy. Key Takeaways: … Read more
The global fight against tuberculosis (TB) has long been hindered by a stagnant pharmaceutical arsenal. For decades, the medical community has relied almost exclusively on the BCG vaccine—a tool that, while effective for infants, leaves adolescents and adults dangerously vulnerable. A new large-scale trial out of India, published in The BMJ, suggests we are finally … Read more
The evolving landscape of substance use is revealing increasingly detailed insights into the impact of both tobacco and cannabis on brain health. A new meta-analysis, published in Addiction, confirms long-suspected structural changes in the brains of tobacco users, while findings regarding cannabis remain more nuanced – a reflection of the rapidly changing potency and patterns … Read more
The seasonal flu isn’t just a respiratory illness; it’s a significant, and often underestimated, cardiovascular risk factor. A compelling new Danish study confirms that influenza infection sharply elevates the risk of heart attack and stroke in the immediate aftermath of illness – but crucially, reveals that vaccination substantially mitigates that risk, even when breakthrough infections … Read more
Beyond One-Size-Fits-All: How AI-Powered Precision Oncology is Rewriting the Future of Cancer Treatment Every two minutes, someone in the US dies from cancer. For decades, the standard approach – surgery, chemotherapy, and radiation – has been largely the same, often delivering a blunt force trauma to the body with varying degrees of success. But a … Read more
The stark disparity in tuberculosis (TB) rates between Inuit communities in Nunavik, Quebec, and the rest of the province – a staggering 1000-fold difference – isn’t merely a public health statistic; it’s a glaring indictment of systemic inequities and historical neglect. New research published in CMAJ underscores what Inuit communities have long known: a culturally … Read more
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Washington D.C. – A dramatic escalation in trade tactics is unfolding as the current administration leverages newly imposed 100% tariffs to compel pharmaceutical companies, ranging from industry giants to emerging biotech startups, … Read more